SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?


To: BD who wrote (804)4/29/1998 2:05:00 PM
From: StockDoc  Respond to of 887
 
Hey Brian, long time no seen. I don't know the Phase IV data. I think that study is still going on. Since that, by definition and protocol (see FDA page) is not a controlled study and has not been prospectively bound to the Phase III, scientific (sound medical) decision in favor of DepoCyt cannot be made. But (!) cheer up, political can. Be patient, politics, lobbying and good personal connections do work in Washington, and facts don't always bother government officials. Your investment may well work out for you. I really hope you gonna get lucky, such fans deserve it. Chances are better then in Las Vegas, for sure.
StockDoc



To: BD who wrote (804)5/4/1998 4:52:00 PM
From: StockDoc  Read Replies (1) | Respond to of 887
 
Brian, I wonder that in light of the ENMD sucess story why cancer drug delivery stocks (MTX, DEPO) did not sink to the bottom. It's interesting. A shot of intrathecal endostatin, huh.
StockDoc